Filociclovir

N/A

Report date: 2026/03/04 15:37:43
NME

Base Information

Drug NameFilociclovir
Drug Alias NameCyclopropavir非昔洛韦Filociclovirum菲络昔洛韦ZSM-I-62 +[7] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionHuman herpesvirus 5 DNA polymerase inhibitorsHuman herpesvirus 1 DNA polymerase inhibitors
TargetsHuman herpesvirus 1 DNA polymeraseHuman herpesvirus 5 DNA polymerase
Therapy Area/IndicationsCytomegalovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMicrobiotix Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMicrobiotix IncNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsCytomegalovirus Infections

Other Information

ATC CodeN/A
Related LinksKEGG